Given that these observations show that signaling through VEGF and its receptors, VEGFR-1 and VEGFR-2, is impaired in hemangioma, the pathway may be important in designing therapeutic strategies for IH. The gene discussed is KDR; the disease is isolated hemihyperplasia.